Company news
Molecule Holdings Inc. (CSE:MLCL) news
Every Molecule Holdings Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Molecule Holdings Inc. Provides Corporate Update
October 27, 2025
Molecule Holdings Inc. Announces Additional Amendment and Conversion Transaction of Unsecured Debentures
June 2, 2025
Molecule Holdings Inc. Announces Issuance of Third Partial Revocation Order
March 4, 2025
Molecule Holdings Inc. Announces Amendment and Conversion of Unsecured Debentures
November 28, 2024
Molecule Holdings Inc. Announces Contract Manufacturing Agreement with Leading Cannabis Company
October 3, 2024
Molecule Holdings Inc. Announces Issuance of Second Partial Revocation Order and Further Details Regarding Debenture Amendments and Priva...
September 3, 2024
Molecule Holdings Inc. Announces Issuance of Partial Revocation Order and Further Details Regarding Debenture Amendments and Private Plac...
May 6, 2024
Molecule Holdings Inc. Announces Issuance of Cease Trade Order, Application for Partial Revocation Order, and Provides Update on Debentur...
March 7, 2024
Molecule Holdings Inc. Announces Revocation of Cease Trade Order and Provides Corporate Update
December 28, 2023
Molecule Holdings Inc. Announces Change of Chief Financial Officer
November 20, 2023
Molecule Holdings Inc. Provides Update on Application for Management Cease Trade Order and Corporate Update
October 6, 2023
Molecule Holdings Inc. Announces Delay of Interim Filings
September 15, 2023
Molecule Holdings Inc. Provides Bi-Weekly MCTO Status Update
April 26, 2023
Molecule Holdings Inc. Announces Debt Financing Transaction and Restructuring of Certain Existing Debt and Update on Order Pipeline
April 11, 2023
Molecule Holdings Inc. Provides Bi-Weekly MCTO Status Update and Update on Interest Payments on Unsecured Debentures
March 31, 2023
Molecule Holdings Inc. Announces Issuance of Management Cease Trade Order by OSC
March 2, 2023
Molecule Holdings Inc. Clarifies Reason for Delay of Annual Filings
February 28, 2023
Molecule Holdings Inc. Announces Amendments to Certain Convertible Debentures and Provides Corporate Update
February 23, 2023
Molecule Holdings Inc. Announces Delay of Annual Filings
February 10, 2023
Molecule Holdings Inc. Announces Entrance into Non-Binding Letter of Intent and Term Sheet with Canna-Day Regarding Acquisition and Priva...
September 28, 2022